CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer-Reference-Cited by-同舟云学术

CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer

Published:2021-05-20 Issue:7 Volume:27 Page:1280-1289
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Bange Erin M.,Han Nicholas A.^ORCID,Wileyto Paul,Kim Justin Y.^ORCID,Gouma Sigrid^ORCID,Robinson James,Greenplate Allison R.,Hwee Madeline A.,Porterfield Florence,Owoyemi Olutosin^ORCID,Naik Karan,Zheng Cathy^ORCID,Galantino Michael,Weisman Ariel R.^ORCID,Ittner Caroline A. G.,Kugler Emily M.,Baxter Amy E.^ORCID,Oniyide Olutwatosin,Agyekum Roseline S.^ORCID,Dunn Thomas G.,Jones Tiffanie K.,Giannini Heather M.^ORCID,Weirick Madison E.,McAllister Christopher M.,Babady N. Esther,Kumar Anita,Widman Adam J.,DeWolf Susan,Boutemine Sawsan R.,Roberts Charlotte,Budzik Krista R.,Tollett Susan,Wright Carla,Perloff Tara,Sun Lova,Mathew Divij^ORCID,Giles Josephine R.,Oldridge Derek A.^ORCID,Wu Jennifer E.,Alanio Cécile^ORCID,Adamski Sharon,Garfall Alfred L.,Vella Laura A.,Kerr Samuel J.,Cohen Justine V.,Oyer Randall A.^ORCID,Massa Ryan,Maillard Ivan P.,Maxwell Kara N.^ORCID,Reilly John P.^ORCID,Maslak Peter G.,Vonderheide Robert H.,Wolchok Jedd D.^ORCID,Hensley Scott E.^ORCID,Wherry E. John^ORCID,Meyer Nuala J.^ORCID,DeMichele Angela M.^ORCID,Vardhana Santosha A.^ORCID,Mamtani Ronac^ORCID,Huang Alexander C.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/s41591-021-01386-7.pdf

Reference67 articles.

1. Blanco-Melo, D. et al. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell 181, 1036–1045 (2020).

2. Hadjadj, J. et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science 369, 718–724 (2020).

3. Arunachalam, P. S. et al. Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans. Science 369, 1210–1220 (2020).

4. Yale IMPACT Team et al. Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature 584, 463–469 (2020).

5. Lee, J. S. et al. Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19. Sci. Immunol. 5, eaabd1554 (2020).

Cited by 355 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Human coronavirus OC43-elicited CD4+ T cells protect against SARS-CoV-2 in HLA transgenic mice;Nature Communications;2024-01-26

3. SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T cell therapy: A prospective, multicenter, observational study (BMT CTN 2101);2024-01-25

4. Cross-protection induced by highly conserved human B, CD4+, and CD8+ T-cell epitopes-based vaccine against severe infection, disease, and death caused by multiple SARS-CoV-2 variants of concern;Frontiers in Immunology;2024-01-22

5. IgG antibody response to SARS-CoV-2 infection and its influencing factors in lymphoma patients;BMC Immunology;2024-01-13